These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21680678)

  • 1. Raltegravir in pregnancy: a case series presentation.
    Taylor N; Touzeau V; Geit M; Gisinger M; Egle A; Greil R; Rieger A; Zangerle R
    Int J STD AIDS; 2011 Jun; 22(6):358-60. PubMed ID: 21680678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV seroconversion in the third trimester of pregnancy: using raltegravir to prevent mother-to-child transmission.
    Hegazi A; Hay P
    Int J STD AIDS; 2013 Mar; 24(3):245-6. PubMed ID: 23440569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting.
    Ferguson W; Goode M; Walsh A; Gavin P; Butler K
    Pediatr Infect Dis J; 2011 May; 30(5):408-12. PubMed ID: 21266939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaesthesia and intensive care characteristics in HIV-infected pregnant patients receiving the antiretroviral therapy].
    Krugova LV; Vartanov VIa; Vartanova IV; Shakhovskaia IN; Khutorskaia NN; Lapteva IV
    Anesteziol Reanimatol; 2010; (6):32-6. PubMed ID: 21400795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus infection and pregnancy.
    Petropoulou H; Stratigos AJ; Katsambas AD
    Clin Dermatol; 2006; 24(6):536-42. PubMed ID: 17113971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing mother-to-child transmission of HIV—protecting this generation and the next.
    Lallemant M; Jourdain G
    N Engl J Med; 2010 Oct; 363(16):1570-2. PubMed ID: 20942674
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases.
    Jaworsky D; Thompson C; Yudin MH; Bitnun A; Brophy J; Samson L; Antoniou T; Loutfy MR
    Antivir Ther; 2010; 15(4):677-80. PubMed ID: 20587860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    Coovadia H
    N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
    [No Abstract]   [Full Text] [Related]  

  • 12. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Herzmann C; Karcher H
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review.
    De Hoffer L; Di Biagio A; Bruzzone B; Sticchi L; Prinapori R; Gerbaldo D; Gotta C; Viscoli C
    J Chemother; 2013 Jun; 25(3):181-3. PubMed ID: 23783144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of pregnancy in HIV-positive women planned for vaginal delivery under effective antiretroviral therapy.
    Islam S; Oon V; Thomas P
    J Obstet Gynaecol; 2010 Jan; 30(1):38-40. PubMed ID: 20121502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of low birthweight infants in HIV-infected women delivered in Rajavithi Hospital.
    Asavapiriyanont S; Kasiwat S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S66-70. PubMed ID: 21717881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National guidelines for the management of HIV-1 in pregnancy.
    Lyons F; Butler K; Coulter Smith S; Mulcahy F
    Ir Med J; 2006 May; 99(5):152-4. PubMed ID: 16892923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Goulder PJ; Blanckenberg N; Dong K
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15529448
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of mother to child HIV transmission.
    Duran AS; Ivalo SA; Hakim A; Masciottra FM; Zlatkes R; Adissi L; Neaton JD; Losso MH
    Medicina (B Aires); 2006; 66(1):24-30. PubMed ID: 16555724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late pregnancy screening for human immunodeficiency virus.
    Steele RW
    Pediatr Infect Dis J; 2011 Jan; 30(1):72-4. PubMed ID: 20686432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.